Biochemical and Biophysical Research Communications
Volume 166, Issue 2, 30 January 1990, Pages 860-866
Phenytoin 4-hydroxylation by rabbit liver P450IIC3 and identification of orthologs in human liver microsomes
References (22)
- et al.
J. Biol. Chem
(1986) - et al.
J. Biol. Chem
(1982) - et al.
J. Biol. Chem
(1985) - et al.
J. Immunolog. Methods
(1987) - et al.
J. Biol. Chem
(1986) - et al.
Ther. Drug. Monit
(1985) - et al.
Clin. Exp. Pharmacol. Physiol
(1976) Clin. Pharmacokin
(1982)- et al.
Neurology
(1964) - et al.
Clin. Pharmacol. Ther
(1980)
Clin. Pharmacol. Ther
(1988)
Cited by (33)
Phenytoin – An anti-seizure drug: Overview of its chemistry, pharmacology and toxicology
2020, Food and Chemical ToxicologyCitation Excerpt :Therefore, CYP3A4-metabolised drugs may generally be required during concurrent treatment with phenytoin (Hole et al., 2018). Research has also been conducted to study phenytoin metabolism in animal subjects (Chow et al., 1980; Billings, 1983; Doecke et al., 1990). It should be noted that rates of 4′-HPPH formation in rat liver microsomes were 10 times higher than in humans (Munns et al., 1997).
Intestinal cytochrome P450 and response to rifampicin in rabbits
2000, Japanese Journal of PharmacologyRole of phenytoin in wound healing - A wound pharmacology perspective
1999, Biochemical PharmacologyLocalization of uridine 5′-diphosphate-glucuronosyltransferase in human liver injury
1995, GastroenterologyPhenytoin parahydroxylation is not impaired in patients with young-onset Parkinson's disease
1994, Clinical Neurology and Neurosurgery
Copyright © 1990 Published by Elsevier Inc.